Heidelberg Pharma AG (ETR:HPHA) | Finanzwire

Basculer en Français

9821	Companies
197095	Keywords
128171	Articles
104822	Press releases

Home
Companies
Heidelberg Pharma AG

BRIEF

published on 09/25/2025 at 10:56, 4 months 12 days ago

Heidelberg Pharma Adjusts Strategy Amid Financial Delays

Cost Reduction Strategic Focus Heidelberg Pharma Milestone Payment ADC Candidate
BRIEF

published on 09/25/2025 at 10:51, 4 months 12 days ago

Heidelberg Pharma Reduces Costs and Focuses on HDP-101 Amid Payment Delay

Cost Reduction Heidelberg Pharma HDP-101 ADC Development Milestone Payment Delay
PRESS RELEASE

published on 09/25/2025 at 10:51, 4 months 12 days ago

Heidelberg Pharma Significantly Reduces Operating Costs and Focuses on Lead ADC Candidate HDP-101 Due to Delayed Milestone Payment
Heidelberg Pharma reduces costs and focuses on lead ADC candidate HDP-101 due to delayed milestone payment. Extensive cost-saving measures implemented

Cost Reduction Heidelberg Pharma HDP-101 Milestone Payment ADC Candidate
PRESS RELEASE

published on 09/25/2025 at 10:46, 4 months 12 days ago

EQS-Adhoc: Heidelberg Pharma Significantly Reduces Operating Costs and Focuses on Lead ADC Candidate HDP-101 Due to Delayed Milestone Payment
Heidelberg Pharma significantly reduces operating costs and focuses on lead ADC candidate HDP-101 due to delayed milestone payment. Extensive cost-saving measures implemented

Operating Costs Heidelberg Pharma Cost-saving Measures Milestone Payment ADC Candidate
BRIEF

published on 09/04/2025 at 09:51, 5 months 3 days ago

Heidelberg Pharma to Present New HDP-101 Data at IMS Annual Meeting

Clinical Data Heidelberg Pharma HDP-101 Multiple Myeloma IMS Annual Meeting
PRESS RELEASE

published on 09/04/2025 at 09:46, 5 months 3 days ago

Heidelberg Pharma Announces New Clinical Data on Lead ATAC Candidate HDP-101 to be Presented at International Myeloma Society Annual Meeting 2025
Heidelberg Pharma announces new clinical data for lead ATAC candidate HDP-101 to be presented at the International Myeloma Society Annual Meeting 2025

Clinical Data Heidelberg Pharma HDP-101 ATAC Candidate International Myeloma Society
BRIEF

published on 08/28/2025 at 03:55, 5 months 11 days ago

FDA Requests Additional Data from Telix Pharmaceuticals, Delaying Payment to Heidelberg Pharma

Heidelberg Pharma Regulatory Update TLX250-CDx FDA Request Financial Implications
PRESS RELEASE

published on 08/28/2025 at 03:50, 5 months 11 days ago

EQS-Adhoc: Heidelberg Pharma’s Partner Telix Pharmaceuticals Gives Regulatory Update for its Imaging Agent TLX250-CDx
Heidelberg Pharma's partner Telix Pharmaceuticals faces delays in TLX250-CDx FDA approval. USD 70 million payment from HealthCare Royalty postponed. Current cash reach until Q1 2026

FDA Approval Heidelberg Pharma HealthCare Royalty Telix Pharmaceuticals TLX250-CDx
BRIEF

published on 07/10/2025 at 07:08, 6 months 28 days ago

Heidelberg Pharma's Promising Mid-Year 2025 Developments

Leadership Changes Royalty Agreement Financial Developments HDP-101 Trials HDP-102 Introduction
PRESS RELEASE

published on 07/10/2025 at 07:03, 6 months 28 days ago

Heidelberg Pharma Reports on First Half-Year 2025 and the Positive Course of Business
Heidelberg Pharma AG reports on positive first half-year 2025 business performance including advancements in ATAC candidates HDP-101 and HDP-102. Financial figures show promising results in line with planning

Financial Report Clinical Trials HDP-101 Heidelberg Pharma AG ATAC Candidates

Accesswire

Published on 02/07/2026 at 01:00, 1 day 4 hours ago

Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 1 day 6 hours ago

Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 1 day 7 hours ago

Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 1 day 13 hours ago

Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 1 day 15 hours ago

Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange

View all ACCESSWIRE

EQS Group

Published on 02/07/2026 at 21:00, 8 hours 27 minutes ago

Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026
Published on 02/07/2026 at 16:35, 12 hours 51 minutes ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
Published on 02/07/2026 at 16:20, 13 hours 6 minutes ago

NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU
Published on 02/06/2026 at 19:25, 1 day 10 hours ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 1 day 11 hours ago

EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG

Les Echos

Published on 02/06/2026 at 18:22, 1 day 11 hours ago

Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 1 day 13 hours ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/05/2026 at 19:24, 2 days 10 hours ago

Minutes of the Combined General Meeting
Published on 02/05/2026 at 18:24, 2 days 11 hours ago

LNA SANTE : 2025 annual sales
Published on 02/05/2026 at 18:06, 2 days 11 hours ago

Aéroports de Paris SA - Shares and voting rights as of 31 January 2026

View all LES ECHOS COMFI WIRE